Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Vonoprazan-based Dual Eradication Therapy vs PPI Treatment on Gastrointestinal Bleeding in ACS Patients With Hp Infection and Coronary Stents: an Open-label, Randomized, Controlled Trial

NCT04728516 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.

NCT NCT04728516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04728516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Vonoprazan-based Dual Eradication Therapy vs PPI Treatment on Gastrointestinal Bleeding in ACS Patients With Hp Infection and Coronary Stents: an Open-label, Randomized, Controlled Trial
Lead sponsor
Qilu Hospital of Shandong University
Phase
Phase 4
Overall status
Recruiting
Start date
April 12, 2023
Completion date
June 30, 2026
Enrollment
2,600 (estimated)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, helicobacter pylori infection